Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Pharmacotherapy
|
July 3, 1999
Bacillus anthracis: medical issues of biologic warfare
K H Ibrahim, G Brown, D H Wright, et al.
Pharmacotherapy
|
November 21, 2001
What do we really know about antibiotic pharmacodynamics?
B W Gunderson, G H Ross, K H Ibrahim, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 8, 1998
Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography
D H Wright, V K Herman, F N Konstantinides, et al.
The Journal of Antimicrobial Chemotherapy
|
November 4, 2000
Application of fluoroquinolone pharmacodynamics
D H Wright, G H Brown, M L Peterson, et al.
Postgraduate Medicine
|
February 1, 1989
Current immunization practices. 2. Hemophilus influenzae, pneumococcal, and meningococcal infections, rabies, and hepatitis
J E Gillum, M W Garrison, K B Crossley, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 19, 2000
Decreased in vitro fluoroquinolone concentrations after admixture with an enteral feeding formulation
D H Wright, S L Pietz, F N Konstantinides, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1996
The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions
A J Larsson, K J Walker, J K Raddatz, et al.
Journal of Clinical Pharmacology
|
December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infection
J C Rotschafer, R A Zabinski, K J Walker, et al.
Postgraduate Medicine
|
February 1, 1989
Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza
J E Gillum, M W Garrison, K B Crossley, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1992
Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model
K Vance-Bryan, T A Larson, J C Rotschafer, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Pharmacotherapy
|
July 3, 1999
Bacillus anthracis: medical issues of biologic warfare
K H Ibrahim, G Brown, D H Wright, et al.
Pharmacotherapy
|
November 21, 2001
What do we really know about antibiotic pharmacodynamics?
B W Gunderson, G H Ross, K H Ibrahim, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
July 8, 1998
Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography
D H Wright, V K Herman, F N Konstantinides, et al.
The Journal of Antimicrobial Chemotherapy
|
November 4, 2000
Application of fluoroquinolone pharmacodynamics
D H Wright, G H Brown, M L Peterson, et al.
Postgraduate Medicine
|
February 1, 1989
Current immunization practices. 2. Hemophilus influenzae, pneumococcal, and meningococcal infections, rabies, and hepatitis
J E Gillum, M W Garrison, K B Crossley, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 19, 2000
Decreased in vitro fluoroquinolone concentrations after admixture with an enteral feeding formulation
D H Wright, S L Pietz, F N Konstantinides, et al.
The Journal of Antimicrobial Chemotherapy
|
October 1, 1996
The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions
A J Larsson, K J Walker, J K Raddatz, et al.
Journal of Clinical Pharmacology
|
December 1, 1992
Pharmacotherapy and pharmacodynamics in the management of bacterial infection
J C Rotschafer, R A Zabinski, K J Walker, et al.
Postgraduate Medicine
|
February 1, 1989
Current immunization practices. 1. Polio, diphtheria, tetanus, pertussis, measles, mumps, rubella, and influenza
J E Gillum, M W Garrison, K B Crossley, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1992
Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model
K Vance-Bryan, T A Larson, J C Rotschafer, et al.
Page
of 9